ID   MUSK_HUMAN              Reviewed;         869 AA.
AC   O15146; Q32MJ8; Q32MJ9; Q5VZW7; Q5VZW8;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-NOV-2010, entry version 96.
DE   RecName: Full=Muscle, skeletal receptor tyrosine-protein kinase;
DE            EC=2.7.10.1;
DE   AltName: Full=Muscle-specific tyrosine-protein kinase receptor;
DE            Short=MuSK;
DE            Short=Muscle-specific kinase receptor;
DE   Flags: Precursor;
GN   Name=MUSK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=96009854; PubMed=7546737; DOI=10.1016/0896-6273(95)90146-9;
RA   Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K.,
RA   Compton D.L., Nunez L., Park J.S., Stark J.L., Gies D.R., Thomas S.,
RA   LeBeau M.M., Fernald A.A., Copeland N.G., Jenkins N.A., Burden S.J.,
RA   Glass D.J., Yancopoulos G.D.;
RT   "Receptor tyrosine kinase specific for the skeletal muscle lineage:
RT   expression in embryonic muscle, at the neuromuscular junction, and
RT   after injury.";
RL   Neuron 15:573-584(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Valenzuela D.M., Rojas E., Yancopoulos G.D.;
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT CONGENITAL MYASTHENIC SYNDROME MET-790.
RX   PubMed=15496425; DOI=10.1093/hmg/ddh333;
RA   Chevessier F., Faraut B., Ravel-Chapuis A., Richard P., Gaudon K.,
RA   Bauche S., Prioleau C., Herbst R., Goillot E., Ioos C., Azulay J.-P.,
RA   Attarian S., Leroy J.-P., Fournier E., Legay C., Schaeffer L.,
RA   Koenig J., Fardeau M., Eymard B., Pouget J., Hantai D.;
RT   "MUSK, a new target for mutations causing congenital myasthenic
RT   syndrome.";
RL   Hum. Mol. Genet. 13:3229-3240(2004).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-27; MET-100; GLU-107; GLY-159;
RP   SER-222; ILE-413; PHE-629; ALA-644; SER-664; LEU-696; ASP-782;
RP   SER-819; LEU-829 AND HIS-858.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase that is a key mediator of
CC       agrin's action and is involved in neuromuscular junction (NMJ)
CC       organization (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with DOK7, which probably regulates its
CC       activity (By similarity). Interacts with PDZRN3; this interaction
CC       is enhanced by agrin (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein (Potential).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O15146-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15146-2; Sequence=VSP_035958, VSP_035959, VSP_035960;
CC       Name=3;
CC         IsoId=O15146-3; Sequence=VSP_035959, VSP_035960;
CC   -!- PTM: Ubiquitinated by PDZRN3. Ubiquitination promotes endocytosis
CC       and lysosomal degradation (By similarity).
CC   -!- DISEASE: Defects in MUSK is a cause of autosomal recessive
CC       congenital myasthenic syndrome (CMS) [MIM:608931]. Congenital
CC       myasthenic syndromes are inherited disorders of neuromuscular
CC       transmission that stem from mutations in presynaptic, synaptic, or
CC       postsynaptic proteins. MUSK mutations lead to decreased agrin-
CC       dependent AChR aggregation, a critical step in the formation of
CC       the neuromuscular junction.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family.
CC   -!- SIMILARITY: Contains 1 FZ (frizzled) domain.
CC   -!- SIMILARITY: Contains 3 Ig-like C2-type (immunoglobulin-like)
CC       domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH69977.1; Type=Erroneous gene model prediction;
CC       Sequence=CAH69978.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI17349.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI17350.1; Type=Erroneous gene model prediction;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/MUSK";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=MuSK entry;
CC       URL="http://en.wikipedia.org/wiki/MuSK_protein";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF006464; AAB63044.1; -; mRNA.
DR   EMBL; AL157881; CAH69977.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL513328; CAH69977.1; JOINED; Genomic_DNA.
DR   EMBL; AL513328; CAI17349.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL157881; CAI17349.1; JOINED; Genomic_DNA.
DR   EMBL; AL157881; CAH69978.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL513328; CAH69978.1; JOINED; Genomic_DNA.
DR   EMBL; AL513328; CAI17350.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL157881; CAI17350.1; JOINED; Genomic_DNA.
DR   EMBL; BC109098; AAI09099.1; -; mRNA.
DR   EMBL; BC109099; AAI09100.1; -; mRNA.
DR   IPI; IPI00289243; -.
DR   IPI; IPI00655599; -.
DR   IPI; IPI00915471; -.
DR   RefSeq; NP_001159752.1; -.
DR   RefSeq; NP_001159753.1; -.
DR   RefSeq; NP_005583.1; -.
DR   UniGene; Hs.521653; -.
DR   ProteinModelPortal; O15146; -.
DR   SMR; O15146; 25-211, 26-290, 217-296, 561-861.
DR   MINT; MINT-2983114; -.
DR   STRING; O15146; -.
DR   PhosphoSite; O15146; -.
DR   PRIDE; O15146; -.
DR   Ensembl; ENST00000374448; ENSP00000363571; ENSG00000030304.
DR   GeneID; 4593; -.
DR   KEGG; hsa:4593; -.
DR   UCSC; uc004bey.2; human.
DR   CTD; 4593; -.
DR   GeneCards; GC09P113431; -.
DR   H-InvDB; HIX0034744; -.
DR   HGNC; HGNC:7525; MUSK.
DR   MIM; 600878; gene.
DR   MIM; 601296; gene.
DR   MIM; 608931; phenotype.
DR   Orphanet; 98913; Postsynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA31326; -.
DR   eggNOG; prNOG06153; -.
DR   HOVERGEN; HBG052539; -.
DR   InParanoid; O15146; -.
DR   BRENDA; 2.7.10.1; 247.
DR   NextBio; 17656; -.
DR   ArrayExpress; O15146; -.
DR   Bgee; O15146; -.
DR   CleanEx; HS_MUSK; -.
DR   Genevestigator; O15146; -.
DR   GermOnline; ENSG00000030304; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0007528; P:neuromuscular junction development; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020716; Tyr_kin_muscle/skeletal_rcpt.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:1.10.2000.10; Frizzled_Cys-rich; 1.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 3.
DR   PANTHER; PTHR23256:SF187; Tyr_kin_muscle/skeletal_rcpt; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL        1     23       Potential.
FT   CHAIN        24    869       Muscle, skeletal receptor tyrosine-
FT                                protein kinase.
FT                                /FTId=PRO_0000024446.
FT   TOPO_DOM     24    495       Extracellular (Potential).
FT   TRANSMEM    496    516       Helical; (Potential).
FT   TOPO_DOM    517    869       Cytoplasmic (Potential).
FT   DOMAIN       28    116       Ig-like 1.
FT   DOMAIN      121    205       Ig-like 2.
FT   DOMAIN      212    302       Ig-like 3.
FT   DOMAIN      312    450       FZ.
FT   DOMAIN      575    856       Protein kinase.
FT   NP_BIND     581    589       ATP (By similarity).
FT   ACT_SITE    725    725       Proton acceptor (By similarity).
FT   BINDING     609    609       ATP (By similarity).
FT   MOD_RES     755    755       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD    222    222       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    338    338       N-linked (GlcNAc...) (Potential).
FT   DISULFID     49     99       By similarity.
FT   DISULFID    142    190       By similarity.
FT   DISULFID    233    282       By similarity.
FT   DISULFID    317    382       By similarity.
FT   DISULFID    325    375       By similarity.
FT   DISULFID    366    406       By similarity.
FT   DISULFID    394    447       By similarity.
FT   DISULFID    398    434       By similarity.
FT   VAR_SEQ     209    209       E -> EEESEPEQDTK (in isoform 2).
FT                                /FTId=VSP_035958.
FT   VAR_SEQ     307    394       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_035959.
FT   VAR_SEQ     454    462       DYNKENLKT -> A (in isoform 2 and isoform
FT                                3).
FT                                /FTId=VSP_035960.
FT   VARIANT      27     27       A -> G (in dbSNP:rs56054734).
FT                                /FTId=VAR_041748.
FT   VARIANT     100    100       T -> M (in dbSNP:rs35142681).
FT                                /FTId=VAR_041749.
FT   VARIANT     107    107       G -> E (in dbSNP:rs55786136).
FT                                /FTId=VAR_041750.
FT   VARIANT     159    159       S -> G (in dbSNP:rs35176182).
FT                                /FTId=VAR_041751.
FT   VARIANT     222    222       N -> S (in dbSNP:rs55826142).
FT                                /FTId=VAR_041752.
FT   VARIANT     413    413       M -> I (in dbSNP:rs2274419).
FT                                /FTId=VAR_021930.
FT   VARIANT     629    629       L -> F (in dbSNP:rs34267283).
FT                                /FTId=VAR_041753.
FT   VARIANT     644    644       V -> A (in dbSNP:rs41279055).
FT                                /FTId=VAR_041754.
FT   VARIANT     664    664       N -> S (in dbSNP:rs55963442).
FT                                /FTId=VAR_041755.
FT   VARIANT     696    696       P -> L (in dbSNP:rs56126328).
FT                                /FTId=VAR_041756.
FT   VARIANT     782    782       E -> D (in dbSNP:rs34614566).
FT                                /FTId=VAR_041757.
FT   VARIANT     790    790       V -> M (in a case of congenital
FT                                myasthenic syndrome; does not affect
FT                                catalytic kinase activity; reduces
FT                                protein expression and stability).
FT                                /FTId=VAR_023046.
FT   VARIANT     819    819       N -> S (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041758.
FT   VARIANT     829    829       V -> L (in dbSNP:rs578430).
FT                                /FTId=VAR_033837.
FT   VARIANT     858    858       R -> H (in dbSNP:rs34115159).
FT                                /FTId=VAR_041759.
SQ   SEQUENCE   869 AA;  97056 MW;  3DDC20E179FA010C CRC64;
     MRELVNIPLV HILTLVAFSG TEKLPKAPVI TTPLETVDAL VEEVATFMCA VESYPQPEIS
     WTRNKILIKL FDTRYSIREN GQLLTILSVE DSDDGIYCCT ANNGVGGAVE SCGALQVKMK
     PKITRPPINV KIIEGLKAVL PCTTMGNPKP SVSWIKGDSP LRENSRIAVL ESGSLRIHNV
     QKEDAGQYRC VAKNSLGTAY SKVVKLEVEV FARILRAPES HNVTFGSFVT LHCTATGIPV
     PTITWIENGN AVSSGSIQES VKDRVIDSRL QLFITKPGLY TCIATNKHGE KFSTAKAAAT
     ISIAEWSKPQ KDNKGYCAQY RGEVCNAVLA KDALVFLNTS YADPEEAQEL LVHTAWNELK
     VVSPVCRPAA EALLCNHIFQ ECSPGVVPTP IPICREYCLA VKELFCAKEW LVMEEKTHRG
     LYRSEMHLLS VPECSKLPSM HWDPTACARL PHLDYNKENL KTFPPMTSSK PSVDIPNLPS
     SSSSSFSVSP TYSMTVIISI MSSFAIFVLL TITTLYCCRR RKQWKNKKRE SAAVTLTTLP
     SELLLDRLHP NPMYQRMPLL LNPKLLSLEY PRNNIEYVRD IGEGAFGRVF QARAPGLLPY
     EPFTMVAVKM LKEEASADMQ ADFQREAALM AEFDNPNIVK LLGVCAVGKP MCLLFEYMAY
     GDLNEFLRSM SPHTVCSLSH SDLSMRAQVS SPGPPPLSCA EQLCIARQVA AGMAYLSERK
     FVHRDLATRN CLVGENMVVK IADFGLSRNI YSADYYKANE NDAIPIRWMP PESIFYNRYT
     TESDVWAYGV VLWEIFSYGL QPYYGMAHEE VIYYVRDGNI LSCPENCPVE LYNLMRLCWS
     KLPADRPSFT SIHRILERMC ERAEGTVSV
//
